Tax-driven share sale by Cryoport (NASDAQ: CYRX) CFO after vesting

Rhea-AI Filing Summary

Cryoport, Inc. Chief Financial Officer Robert Stefanovich reported a small, tax-related share sale. On this Form 4, he sold 1,094 shares of common stock at $8.18 per share, with a footnote stating the shares were required to be sold under company policy to pay taxes due upon the vesting of restricted stock rights. After the transaction, he directly holds 279,277 shares, indicating this was a routine withholding event tied to equity compensation rather than a discretionary reduction of his overall stake.

Insider Trade Summary

Net Seller: 1,094 shares ($8,949)

Net Sell 1 txn

Insider STEFANOVICH ROBERT

Role Chief Financial Officer

Sold 1,094 shs ($9K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,094	$8.18	$9K

Holdings After Transaction: Common Stock — 279,277 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STEFANOVICH ROBERT

(Last) (First) (Middle)

C/O CRYOPORT INC.

112 WESTWOOD PLACE, SUITE 350

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/23/2026		S(1)		1,094	D	$8.18	279,277	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

	/s/ Robert Stefanovich	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cryoport (CYRX) disclose for its CFO?

Cryoport disclosed that CFO Robert Stefanovich reported a sale of 1,094 common shares. The shares were sold at $8.18 each to satisfy tax obligations arising from the vesting of restricted stock rights under company policies, rather than a discretionary portfolio move.

Why did Cryoport CFO Robert Stefanovich sell 1,094 CYRX shares?

The 1,094 shares were sold to cover taxes due on vesting restricted stock rights. A footnote explains the sale was required under Cryoport’s policies, meaning it functioned as tax withholding linked to equity compensation, not a strategic decision to reduce his investment.

How many Cryoport shares does the CFO hold after this Form 4 transaction?

Following the tax-related sale, CFO Robert Stefanovich holds 279,277 Cryoport common shares directly. This remaining position is large compared with the 1,094 shares sold, underscoring that the filing reflects a routine compensation-related event rather than a major change in his ownership.

Was the Cryoport CFO’s reported sale an open-market disposition of CYRX stock?

While coded as an open-market sale, the filing notes the shares were required to be sold to pay taxes on vesting restricted stock rights. This characterizes the event as a mechanically driven tax settlement under company policy, not a discretionary open-market liquidation.

Does this Cryoport Form 4 indicate any derivative or option exercises by the CFO?

The data shows no derivative transactions or option exercises associated with this Form 4. The event strictly involves common stock sold to cover tax obligations from vesting restricted stock rights, with no remaining derivative positions reported in the derivative summary section.